These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32745151)

  • 21. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.
    Boman A; Brink M; Lundquist A; Hansson M; Mathsson-Alm L; Rönnelid J; Berglin E; Holmdahl R; Skriner K; Serre G; Klareskog L; Rantapää-Dahlqvist S
    RMD Open; 2019; 5(2):e000946. PubMed ID: 31565241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
    Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
    Front Immunol; 2018; 9():876. PubMed ID: 29740454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia.
    van Beers-Tas MH; Marotta A; Boers M; Maksymowych WP; van Schaardenburg D
    Arthritis Res Ther; 2016 Apr; 18():76. PubMed ID: 27037016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis.
    Bugatti S; Bogliolo L; Vitolo B; Manzo A; Montecucco C; Caporali R
    Arthritis Res Ther; 2016 Oct; 18(1):226. PubMed ID: 27716332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brief report: accelerated aging influences cardiovascular disease risk in rheumatoid arthritis.
    Crowson CS; Therneau TM; Davis JM; Roger VL; Matteson EL; Gabriel SE
    Arthritis Rheum; 2013 Oct; 65(10):2562-6. PubMed ID: 23818136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis Are Associated with Autoantibody Status.
    Chalan P; Bijzet J; Kroesen BJ; Boots AM; Brouwer E
    J Rheumatol; 2016 Jun; 43(6):1008-16. PubMed ID: 27036380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se.
    Murphy D; Mattey D; Hutchinson D
    PLoS One; 2017; 12(7):e0180655. PubMed ID: 28708862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Prospective Study of the Development of Inflammatory Arthritis in the Family Members of Indigenous North American People With Rheumatoid Arthritis.
    Tanner S; Dufault B; Smolik I; Meng X; Anaparti V; Hitchon C; Robinson DB; Robinson W; Sokolove J; Lahey L; Ferucci ED; El-Gabalawy H
    Arthritis Rheumatol; 2019 Sep; 71(9):1494-1503. PubMed ID: 30861615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA.
    Hecht C; Englbrecht M; Rech J; Schmidt S; Araujo E; Engelke K; Finzel S; Schett G
    Ann Rheum Dis; 2015 Dec; 74(12):2151-6. PubMed ID: 25115448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for cardiovascular disease in rheumatoid arthritis patients from Mato Grosso do Sul.
    de Deus Junior RS; Ferraz AL; Oesterreich SA; Schmitz WO; Shinzato MM
    Rev Bras Reumatol; 2015; 55(6):493-500. PubMed ID: 26362702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of joint ultrasonography in predicting arthritis in seropositive patients with arthralgia: a prospective cohort study.
    van Beers-Tas MH; Blanken AB; Nielen MMJ; Turkstra F; van der Laken CJ; Meursinge Reynders M; van Schaardenburg D
    Arthritis Res Ther; 2018 Dec; 20(1):279. PubMed ID: 30567606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy.
    Jonsson MK; Hensvold AH; Hansson M; Aga AB; Sexton J; Mathsson-Alm L; Cornillet M; Serre G; Lillegraven S; Fevang BS; Catrina AI; Haavardsholm EA
    Arthritis Res Ther; 2018 Jul; 20(1):146. PubMed ID: 30001740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events.
    Gouze H; Aegerter P; Said-Nahal R; Zins M; Goldberg M; Morelle G; Schett G; Breban M; D'Agostino MA
    Arthritis Res Ther; 2022 Feb; 24(1):56. PubMed ID: 35209936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives.
    Hitchon CA; Chandad F; Ferucci ED; Willemze A; Ioan-Facsinay A; van der Woude D; Markland J; Robinson D; Elias B; Newkirk M; Toes RM; Huizinga TW; El-Gabalawy HS
    J Rheumatol; 2010 Jun; 37(6):1105-12. PubMed ID: 20436074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient burden and joint inflammation during development of RA from arthralgia: is it similar in ACPA-positive and ACPA-negative disease?
    Khidir SJH; Krijbolder DI; Glas HK; van Mulligen E; van der Helm-van Mil AHM
    Rheumatology (Oxford); 2024 Sep; 63(9):2336-2344. PubMed ID: 38261628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vapour, gas, dust and fume occupational exposures in male patients with rheumatoid arthritis resident in Cornwall (UK) and their association with rheumatoid factor and anti-cyclic protein antibodies: a retrospective clinical study.
    Murphy D; Bellis K; Hutchinson D
    BMJ Open; 2018 May; 8(5):e021754. PubMed ID: 29773705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of autoantibody responses in individuals at risk of rheumatoid arthritis.
    Falkenburg WJJ; van Schaardenburg D
    Best Pract Res Clin Rheumatol; 2017 Feb; 31(1):42-52. PubMed ID: 29221597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors of Progression and Occurrence of Atherosclerosis in Rheumatoid Arthritis.
    Fomicheva OA; Popkova TV; Krougly LB; Gerasimova EV; Novikova DS; Pogorelova OA; Tripoten MI; Balakhonova TV; Karpov YA; Nasonov EL
    Kardiologiia; 2021 Feb; 61(1):12-21. PubMed ID: 33734051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-limiting arthritis among patients fulfilling the 2010 ACR/EULAR classification criteria for rheumatoid arthritis in a very early arthritis cohort.
    Norli ES; Brinkmann GH; Kvien TK; Bjørneboe O; Haugen AJ; Nygaard H; Thunem C; Lie E; Mjaavatten MD
    Semin Arthritis Rheum; 2016 Dec; 46(3):272-278. PubMed ID: 27546493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.